GLORIFARM BOTANICALS PRIVATE LIMITED

In their own words

Overview Glorifarm Botanicals Private Limited is a life sciences company engaged in cultivation, research, supply and services of botanical ingredients needed for the global pharmaceutical industry. Market Landscape The pharmaceutical industry is expected to grow at an impressive CAGR of 6.5% over the next five years. The industry growth is lead by changing lifestyles, aging population, and not-so-healthy eating habits across the entire global population. And, the industry continues to face competition, increasingly from the emerging markets. Significant volatility in the price and availability of botanical ingredients pose immense challenge to the industry. Opportunity Efficient and effective supply chain management is critical for pharmaceutical companies to leverage the growth opportunity while combating competition and managing uncertainty. Gloriosa Superba (the “Biomass”) is one of the key plant sources from which ingredients are derived from. But, the plant characteristics have made it challenging for vendors to procure the biomass for their activities. Vendors struggle to procure the required level of biomass at the right quality level on the required time-lines at appropriate price-points. The Glorifarm Advantage Balancing this complex, often competing factors requires specialized skills, knowledge, and more importantly global networks and channels along with technology expertise. And, that is exactly what Glorifarm brings to the table. This enables the pharmaceutical companies to focus on their core strategic areas – research, production, and sales - while Glorifarm brings in predictability and eliminates uncertainty in the supply chain. Glorifarm possesses skills, knowledge, and processes to efficiently procure right quality biomass at scale through its’ channel network. Glorifarm will build predictability and contain the price volatility by leveraging its global network, through own and managed cultivation at scale with partner networks globally. Glorifarm is committed to focus on life sciences research. It will own and operate research and development facilities in India to carry out the objectives. It will also co-operate with world-class universities and research centers on multiple levels. Research objectives span the following areas: • Evaluation of medicinal plants for pharmacological applications • Nurturing and improving the health of the plants • Leveraging tissue culture technologies • Building cost-effective methods for large-scale production. • Co-operation in traceability initiatives Glorifarm will also work with information technology partners to map the supply chain ecosystem, model the interactions and variables, and leverage data. This will help create visibility, provide insights and forecasting ability and in essence provide superior supply chain intelligence. Closing Glorifarm will continue to strengthen the partnership with key strategic customers, while addressing the larger market. Glorifarm’s vision is to become a strong, global leader in the pharmaceutical supply chain by providing differentiated value to the customers, with the power of technology.

Written by the company on its public Startup India profile. Not verified by us.